Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to ...
WPBN Traverse City/Cadillac on MSN3d
Munson Healthcare adds 25 Narcan distribution boxes in northern Michigan
Munson Healthcare is taking steps to make sure Narcan is accessible to everyone.It's partnering with Harm Reduction Michigan ...
There’s a new opioid antidote. But Mass. health officials are hesitant to endorse it
A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...
The Herald News11d
Do Fall River students need to learn how to use Narcan? School board says yes
FALL RIVER — At a Jan. 13 meeting, the School Committee voted in favor of teaching 11th and 12th graders how to administer ...
cbc.ca on MSN9d
UNB spreads naloxone kits around campuses
The University of New Brunswick has placed nasal spray naloxone kits around its campuses for emergency opioid overdose ...
Hosted on MSN12d
EBS obtains rights to Hikma's Kloxxado naloxone spray
Emergent BioSolutions (NYSE:EBS) has entered into an agreement for the exclusive commercial rights in the U.S. and Canada for ...
Yahoo Finance12d
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Alongside over-the-counter NARCAN ® Nasal Spray 4 mg, prescription KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose ...
Nasdaq12d
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S ...